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Summary of results 
 
This paper presents new NDRDI figures on drug-related deaths and deaths among drug users in 2006 and 
2007, and updates previously published figures for the years 1998–2005.  
 
Overview 
• Between 1998 and 2007 a total of 3,465 drug-related deaths and deaths among drug users met the 
criteria for inclusion in the NDRDI database. Of these deaths, 2,120 were due to poisoning and 
1,345 were due to traumatic or medical causes (non-poisoning) (Table 1). 
• In 1998, almost three-quarters (73.6%) of drug-related deaths recorded in the NDRDI were 
poisonings. The percentage of such deaths decreased over the 10-year reporting period, with 57% 
of deaths in 2007 due to poisoning and 42% to other causes (non-poisoning). 
• The annual number of deaths more than doubled in nine years, rising from 242 in 1998 to 491 in 
2006. The number fell to 476 in 2007, but this figure may be revised upwards when data relating to 
late inquests becomes available (Table 1). 
 
Poisoning deaths 
• The annual number of deaths by poisoning increased from 178 in 1998 to 274 in 2007. (Table 1) 
• Males accounted for 68% of deaths by poisoning (Figure 1).  
• The majority of those who died by poisoning were aged between 20 and 40 years. The median age 
was 34 years (Figure 2 and Table 2). 
• Just over half of all deaths by poisoning involved more than one substance (polysubstance cases)  
(Table 3). 
• Heroin and other opiates, including methadone, were implicated in over half (55.3%, 1,172) of all 
deaths by poisoning. 
• The number of deaths by poisoning where cocaine was implicated rose from five in 1998 to 63 in 
2007. Cocaine was implicated in 10% of all deaths by poisoning in the 10-year period (Table 4). 
• Prescription and over-the-counter medication was implicated in many of the deaths by poisoning.  
Benzodiazepines continued to play a major role in polysubstance poisonings, being involved in more 
deaths by poisoning than any other substance in the reporting period (Table 4). 
• Since 2003, more deaths by poisoning occurred outside Dublin than inside Dublin (city and county) 
(Figure 3).  
• The number of poisoning deaths increased in all but two of the regional drugs task force (RDTF) 
areas between 1998 and 2007 (Table 5). The South Western RDTF area recorded the highest 
number of deaths (n = 478) for the 10-year period.  
 
Non-poisoning deaths  
• A total of 1,345 non-poisoning deaths among drug users were recorded between 1998 and 2007.  
• Of the 1,183 non-poisoning cases with a known cause of death, almost two thirds (60.3%, 714) 
were due to trauma and 40% (469) were due to medical causes (Figure 4). 
 
Deaths due to trauma 
• The annual number of deaths due to trauma increased from 39 in 1998 to 116 in 2006, but 
decreased to 87 in 2007 (Figure 4).  These figures may be revised when data relating to late 
inquests becomes available.  
• Half (50.4%, 360) of those who died from traumatic causes were aged between 20 and 29 years 
(Figure 6). The median age was 27 years.  Almost all (643, 90.1%) of those who died were male. 
• The most common causes of death due to trauma were hanging and road traffic collisions (Figure 7). 
 
Deaths due to medical causes 
• The annual number of deaths due to medical causes rose fairly steadily over the reporting period, 
increasing from 11 in 1998 to 98 in 2007, when it exceeded the number of deaths due to trauma 
(Figure 4). 
• The majority of those who died from medical causes were aged between 30 and 44 years (Figure 9).  
The median age was 39 years. Three-quarters (352, 75.0%) of those who died were male.  
• The most common medical causes of death were cardiac events (118, 25.2%), respiratory infections 
(83, 17.7%) and liver disease (48, 10.2%) (Figure 10). 
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Glossary  
 
Drug users: Individuals who have a history of drug dependency or of non-dependent abuse of drugs 
and/or other substances 
 
Illicit drugs: Heroin, cocaine, cannabis, MDMA, LSD, volatile inhalants etc.  
 
Median: The median is the value at the mid-point in a sequence of numerical values ranged in ascending or 
descending order. It is defined as the value above or below which half of the values lie.  Unlike the mean 
(average), the median is not influenced by extreme values (or outliers). For example, in the case of five drug 
users aged 22, 23, 24 and 46 years respectively, the median (middle value) is 24 years, whereas the mean 
is 27.8 years. While both the median and the mean describe the central value of the data, the median is 
more useful in this case because the mean is influenced by the one older person in this example. 
 
Medical categories of death: Cases in which more than one medical condition was listed as the cause of 
death were categorised by the main cause of death.  The main categories of death from medical causes 
include: 
 
• Cerebral event: e.g. cerebral haemorrhage, cerebral vascular disease and disorders of the brain 
• Other infection(s): e.g. bacterial or other viral diseases 
• Respiratory disease: e.g. asthma, chronic obstructive pulmonary disease or emphysema 
• Respiratory infection: e.g. pneumonia or pneumonitis due to the inhalation of solids or liquids 
 
Non-poisoning deaths: Deaths in individuals with a history of drug dependency or non-dependent abuse 
of drugs (ascertained from toxicology results and from Central Treatment List, medical or coronial records) 
whether or not the use of the drug was directly implicated in the death  
 
Poisoning deaths: Deaths which are directly due to the toxic effect of the presence in the body of one or 
more drugs and/or other substance(s) 
 
Trauma: A serious injury to the body, often the result of violence or accident 
 
 
This document should be cited as:  Health Research Board (2010). Drug-related deaths and deaths among 
drug users in Ireland, 1998 to 2007. Data from the National Drug-Related Deaths Index.  Available at 
www.hrb.ie/publications 
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Acronyms 
 
 
AIDS  Acquired Immune Deficiency Syndrome 
BBV  Blood-borne virus 
CSO  Central Statistics Office 
CTL  Central Treatment List 
EMCDDA European Monitoring Centre for Drugs and Drug Addiction  
ESRI  Economic and Social Research Institute 
FSN  Family Support Network 
HIPE   Hospital In-Patient Enquiry scheme 
HIV  Human immunodeficiency virus 
HRB   Health Research Board 
ICD  International Classification of Diseases 
LDTF  Local drugs task force 
LSD  Lysergic acid diethylamide 
MDMA  3,4-Methylenedioxymethamphetamine, also known as ecstasy 
NDRDI  National Drug-Related Deaths Index 
RDTF  Regional drugs task force 
RTC  Road traffic collision 
 
In the case of data presented by region, this paper refers to the areas covered by the regional drugs task 
forces (RDTFs), together with the local drugs task forces (LDTFs) within their boundaries, as follows:  
 
Task force Area included 
ECRDTF 
East Coast Regional Drugs Task Force 
(DTF) 
South-east Dublin city and county and East Wicklow, 
including the two LDTF areas within these boundaries  
MRDTF Midland Regional DTF Counties Laois, Longford, Offaly and Westmeath 
MWRDTF Mid West Regional DTF Counties Clare and Limerick, and North Tipperary 
NDRDTF 
North Dublin City and County 
Regional DTF 
North Dublin city and county, including the five LDTF 
areas within these boundaries 
NERDTF North Eastern Regional DTF Counties Cavan, Louth, Meath and Monaghan 
NWRDTF North West Regional DTF 
Counties Donegal, Leitrim and Sligo, and north-west 
Cavan 
SERDTF South East Regional DTF 
Counties Carlow, Kilkenny, Waterford and Wexford, and 
South Tipperary, 
SRDTF Southern Regional DTF Counties Cork and Kerry, including the Cork LDTF area 
SWRDTF South Western Regional DTF 
South-west Dublin, west Wicklow and County Kildare, 
including the six LDTF areas within these boundaries 
WRDTF Western Region DTF Counties Galway, Mayo and Roscommon 
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Introduction 
 
The Irish National Drug-Related Deaths Index (NDRDI) is an epidemiological database which records cases 
of death by drug and alcohol poisoning, and deaths among drug users and those who are alcohol 
dependent.1, 2 The NDRDI is maintained by the Health Research Board (HRB). It is jointly funded by the 
Department of Health and Children and the Department of Justice, Equality and Law Reform.   
 
The NDRDI was established in September 2005 to comply with Action 67 of the 2001–2008 National Drugs 
Strategy.3  The aim of Action 67 was to put in place a system for recording drug-related deaths to enable 
the State and its agencies to respond in a timely manner, with accurate data.   
 
The number of drug-related deaths and deaths among drug users is one of the key indicators used to 
measure the consequences of problem drug use in Europe. The NDRDI enables accurate reporting of these 
key data to the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). The EMCDDA has 
recommended that all EU member states establish a special register to record these deaths.  
 
 
Aim and objectives of the NDRDI 
 
The aim of the NDRDI is to ensure complete (90%) and accurate (95%) reporting of drug- and alcohol-
related deaths, and deaths among drug users and among those who are alcohol dependent, in order to 
allow the State and its agencies to respond in a timely manner. 
 
Objectives of the NDRDI: 
• To provide accurate information on drug- and alcohol-related deaths and deaths among drug users 
and among those who are alcohol dependent. 
• To assist in identifying and prioritising areas for intervention and prevention, and to measure the 
effects of such interventions. 
 
Background 
 
Drug use can lead to premature death from a range of different causes.4  Many deaths are caused by 
poisoning (both intentional and unintentional), where the death is directly attributable to the consumption of 
drugs (alone or in combination with other substances).  This type of death is often defined as a directly 
drug-related death.  For the purposes of this paper, this type of death is referred to as a poisoning.  
 
Deaths among drug users (whether the user is dependent or non-dependent) may be indirectly attributed to 
their drug use. This type of death is often defined as an indirectly drug-related death.  For the purpose of 
this paper, this type of death is referred to as a non-poisoning. Causes of death in such cases include:  
 
• infection with HIV as a result of sharing drug paraphernalia, and subsequent development of an AIDS-
related illness; 
• the harmful effects of drug use (both short and long term) on the health of the drug user, such as the 
cardio-toxic effect of cocaine or drug-related liver disease;5, 6, 7, 8   
• actions taken while under the influence of drugs, such as accidents caused by impaired judgement or 
exacerbation of risky behaviours;4, 5  
• psychiatric illness as a co-morbid condition, which places the individual at a greater risk of suicide.4, 9, 10, 11  
 
In line with international practice, deaths as the result of the drug use of another individual, such as a road 
traffic accident or an assault, are not recorded by the NDRDI. 
 
Alcohol consumption has been reported as the third most detrimental risk factor for ill health and premature 
death in Europe.12  While the NDRDI has recorded data on alcohol-related deaths and deaths among those 
who are alcohol dependent since 2004, these data are not presented in this paper.  Alcohol is included in the 
analysis presented in this paper only when it features as an additional addiction, and/or as part of a 
polysubstance finding in toxicology.  
 
Most cases of drug misuse or dependence involve illicit drugs; however, licit drugs also may be misused and 
may lead to dependency.  These deaths are also included in the NDRDI. 
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A documented history of drug dependence or drug use is not available in all cases, leading to an under-
recording of the total number of non-poisoning deaths in the drug-using population. 
 
Calculation of mortality figures for both poisonings and non-poisonings provides an estimate of the total 
burden of mortality related to drug use in Ireland. 
 
 
Methods 
 
The data-collection tool was developed from those used in previous research and from tools devised by the 
EMCDDA. Data were collected retrospectively for each of the 10 years between 1998 and 2007.   
 
Data collected include: 
• demographic details 
• socio-economic information 
• history of drug or alcohol dependence or non-dependent abuse of drugs 
• risk factors, e.g. history of injecting, imprisonment 
• drug or alcohol treatment history 
• details about the death itself: 
 toxicology 
 cause of death. 
 
Data sources 
 
In order to ensure a complete and accurate database, the NDRDI records data from several sources: the 
Coroner Service, the acute hospital sector through the Hospital In-Patient Enquiry (HIPE) scheme, the 
Central Treatment List (CTL) of clients prescribed methadone, the General Mortality Register (GMR) and the 
Family Support Network (FSN), a community representative body.  
 
The Coroner Service 
The primary objective of the Coroner Service is to establish, following public investigation, the cause of 
death (including how the person died) in cases of sudden or unexpected death.13  In Ireland, a coroner has 
the same absolute privileges as a judge.  To establish the cause of death, the coroner can instigate further 
inquiries, such as ordering a post-mortem and, if necessary, an inquest.  If the results of the post-mortem 
and any other tests establish the cause of death as being natural, the coroner can then issue a certificate to 
the Registrar of Births, Deaths and Marriages, enabling that office to issue a death certificate. 
 
An inquest is an inquiry in public by a coroner, sitting with or without a jury, into the circumstances 
surrounding a death.  An inquest must be held by law if a death could be due to unnatural causes.  An 
inquest is concerned with establishing the facts of the death, rather than determining the innocence or guilt 
of any third party.  Once the inquest has been completed, the final outcome is a matter of public record.  
The cause of death as determined by the coroner is recorded in the NDRDI. 
 
NDRDI researchers collect data on closed inquests on site from the 47 coroner districts countrywide. The 
data are entered directly into the database on laptops secured by encryption.  The time between date of 
death and completion of inquest varies from case to case.14  Because of this, information on some deaths 
that occurred during the reporting period was not available from the coroners. The NDRDI database is 
updated as and when the verdicts from these inquests become available and amended figures will be 
presented in future publications.  
   
The Hospital In-Patient Enquiry (HIPE) scheme 
The Economic and Social Research Institute (ESRI) manages the HIPE scheme.  HIPE is a computer-based 
health information system designed to collect medical and administrative data on discharges and deaths in acute 
hospitals.   
 
Sixty acute hospitals participate in the HIPE scheme. The estimated coverage of cases discharged from these 
hospitals was approximately 95.5% between 1999 and 2004.15 The International Classification of Diseases 
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(ICD) codes used by HIPE changed over the reporting period (from ICD9 CM to ICD10 AM), which may have 
led to some small differences in classification of cases.   
  
An automated programme was developed by the HIPE information technology department of the ESRI to 
extract the required information from the HIPE database on cases who died in hospital and had the 
appropriate ICD codes. Ninety-eight per cent of HIPE hospitals provided data, which the NDRDI researchers 
download on site in each hospital.   
 
The Central Treatment List (CTL) 
The CTL was established under Statutory Instrument No. 225 following publication of the Report of the 
Methadone Treatment Services Review Group 1998.16  This list is administered by the Drug Treatment 
Centre Board on behalf of the Health Service Executive and is a complete register of all clients in Ireland 
receiving methadone for treatment of opiate misuse.  The data on all deaths reported to CTL staff are sent 
electronically in a secure format to the NDRDI. 
 
The General Mortality Register (GMR) 
The Registrar of Births, Deaths and Marriages formally records all notified deaths in Ireland.  Using these 
data, the Central Statistics Office (CSO) categorises each death and the underlying cause of death using ICD 
codes, and returns this information to the GMR.  If the gardaí investigate a death on behalf of the Coroner 
Service, they also provide supplementary information related to the death to the CSO (Form 104). In the 
case of each death, only one underlying cause of death and only one external cause, which describes the 
circumstances under which the death occurred, are recorded.  The main disadvantage of this method of 
recording is that contributory factors, such as drug use, may not be recorded.  GMR data is collected on site. 
 
The Family Support Network (FSN) 
The FSN was established in 2000 by the CityWide Drugs Crisis Campaign. It consists of national 
representatives of family support groups, individual family members and those working directly with the 
families of drug users.  Information on drug-related deaths may be given voluntarily by family members to 
personnel from the Network, who then forward it to the NDRDI. Informed consent is required prior to data 
collection.  The FSN data collection is still in its pilot phase and the analysis presented in this paper does not 
include data from the FSN. 
 
Ethical approval 
 
Ethical approval for the NDRDI was obtained from the HRB ethics committee and from ethics committees 
covering each hospital providing HIPE data.  Approval for the use of CTL data was obtained from the 
Methadone Prescribing Protocol Implementation Committee. All work was carried out in accordance with the 
IEA/European Epidemiology Group guideline document.17 
 
 
Case matching 
 
Cases from the data sources described above were cross-matched on a selection of variables, including 
name, gender, county of residence, date of birth and date of death. This allows the NDRDI to eliminate 
duplicates and to maximise the amount of information available on each case recorded on the database. 
Named data were not available from the GMR for the period 1998 to 2005; to avoid duplication and over-
estimation of the number of cases, GMR cases with no match are not included in the NDRDI for those years.   
  
 
Types of cases included in the NDRDI 
 
Poisonings: Deaths directly due to the toxic effect of the presence in the body of a drug or drugs and/or 
other substance(s). Other terms used to describe such deaths include overdose, directly drug-related death 
and acute drug death.  Deaths arising from adverse reactions to prescribed medication are not included in 
the NDRDI. 
 
Non-poisonings: Deaths in individuals with a history of drug dependency or non-dependent abuse of drugs 
(ascertained from toxicology results and from CTL, medical or coronial records), irrespective of whether the 
use of the drug was directly implicated in the death.  
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Results 
 
 
Between 1998 and 2007, 3,465 drug-related deaths and deaths among drug users met the criteria for 
inclusion in the NDRDI.  Data on these cases were obtained from four sources, and almost two-thirds 
(63.5%, 2,202) appeared in more than one source. 
 
Previously reported figures for the years 1998–2005 have been updated to include data from the Coroner 
Service from late inquests. Similarly, figures for the years 2006 and 2007 may be revised when data relating 
to late inquests becomes available.  
 
 
Table 1   Drug-related deaths, by year of death, NDRDI 1998 to 2007 (N=3,465) 
 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 
All deaths 242 271 261 277 338 297 365 447 491 476 
Poisoning ( n=2120) 178 187 182 178 211 185 207 248 270 274 
Non-poisoning (n=1345) 64 84 79 99 127 112 158 199 221 202 
 
 
 
 
 
Poisoning deaths  
 
 
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007
Male 126 136 117 121 137 120 133 169 194 192
Female 52 51 65 57 74 65 74 79 76 82
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Figure 1   Poisoning deaths, by gender and by year, NDRDI 1998 to 2007 (N=2,120) 
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Figure 2   Poisoning deaths, by age group, NDRDI 1998 to 2007 (N=2,120) 
 
 
 
 
 
Table 2   Poisoning deaths, by median age and by gender, NDRDI 1998 to 2007 (N=2,120) 
 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 
 Years 
Median 35 33 35 35 34 36 36 35 34 33 
Age range* 19–69 17–67 17–69 20–64 17–64 18–68 20–70 17–64 20–62 18–63 
Male 32 31 33 33 33 33 32 32 33 31 
Female 42 41 39 37 38 39 47 42 40 40 
* Age range presented is the 5th to the 95th percentile (90% of cases are included within this range). 
 
 
 
 
 
Table 3   Single-drug and polysubstance poisoning deaths, NDRDI 1998 to 2007 (N=2,120) 
 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 
Poisonings  n (%) 
Single-drug  
(n=985) 
79 
(44.4) 
91 
(48.7) 
82 
(45.1) 
89 
(50.0) 
94 
(44.5) 
84 
(45.4) 
92 
(44.4) 
115 
(46.4) 
141 
(52.2) 
118 
(43.1) 
Polysubstance 
(n=1135) 
99 
(55.6) 
96 
(51.3) 
100 
(54.9) 
89 
(50.0) 
117 
(55.5) 
101 
(54.6) 
115 
(55.6) 
133 
(53.6) 
129 
(47.8) 
156 
(56.9) 
Total 178 187 182 178 211 185 207 248 270 274 
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Table 4   Drugs involved in poisoning deaths, NDRDI 1998 to 2007 (N=2,120) 
 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007  Total % 
All deaths* 178 187 182 178 211 185 207 248 270 274  2120 100 
Heroin 29 48 37 48 46 28 29 48 66 63  442 20.8 
Methadone 43 37 40 28 39 34 40 43 60 50  414 19.5 
Other opiates† 39 35 45 54 47 48 65 67 55 55  510 24.1 
Cocaine 5 5 5 8 14 10 19 36 52 63  217 10.2 
MDMA 4 8 8 6 10 11 13 10 6 11  87 4.1 
              
Benzodiazepines 78 72 73 55 71 62 76 80 113 113  793 37.4 
Alcohol‡ 35 43 38 38 57 49 63 65 53 77  518 24.4 
Antidepressants 32 34 41 40 47 44 51 54 43 40  426 20.1 
Other prescription 
drug § 38 37 35 18 33 37 41 37 39 60  375 17.7 
Non-opiate 
analgesics 12 17 11 16 16 11 12 22 13 16  146 6.9 
              
Other¶ 14 17 13 13 21 14 9 21 21 24  167 7.9 
* Numbers and percentages in columns do not add up to totals shown in this row because individual deaths may be attributable to 
more than one drug or substance. 
† Includes unspecified opiates and analgesics containing an opiate compound. 
‡ Alcohol is recorded only when it contributes to a polysubstance death. 
§ Includes non-benzodiazepine sedatives, anti-psychotics, cardiac and all other types of medication, including over-the-counter 
medication. 
¶ Includes solvents, insecticides, herbicides, barbiturates, other amphetamines, hallucinogens, cannabis and other chemicals. 
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Figure 3   Poisoning deaths, by place of residence, NDRDI 1998 to 2007 (N=2,120) 
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Table 5   Poisoning deaths, by task force area, NDRDI 1998 to 2007 (N=2,120)  
 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 
SWRDTF 51 50 44 51 54 30 42 45 60 51 
NDRDTF 42 48 48 37 49 38 36 50 69 54 
SRDTF 14 23 21 21 29 31 24 28 33 43 
ECRDTF 13 15 14 12 19 10 23 32 19 17 
SERDTF 10 8 13 12 10 21 20 17 15 27 
NERDTF 9 11 8 9 17 10 14 13 17 13 
MWRDTF 6 9 9 7 10 16 14 17 12 15 
WRDTF 14 10 9 12 ~ 11 9 13 10 15 
MRDTF ~ 6 7 9 5 8 10 12 14 9 
NWRDTF 6 ~ ~ ~ 9 5 9 10 7 ~ 
Other/Unknown 11 ~ 5 ~ 5 5 6 11 14 28 
~ Less than five cases 
 
Non-poisoning deaths from traumatic and medical causes 
 
Between 1998 and 2007, 1,345 non-poisoning deaths were recorded among drug users.  The cause of death 
was known in 1,183 (88.0%) of these cases.   
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007
Trauma 39 41 51 60 67 55 85 113 116 87
Medical 11 27 18 23 45 29 55 65 98 98
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Figure 4   Non-poisoning deaths among drug users, NDRDI 1998 to 2007 (N=1,183) 
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Figure 5   Non-poisoning deaths among drug users, by regional drugs task force area, NDRDI 1998 
to 2007 (N=1,056) 
* Numbers for the two categories are combined as the number of deaths from medical causes was less than five for the reporting 
period. 
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Deaths due to trauma 
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Figure 6   Deaths among drug users due to trauma, by age group, NDRDI 1998 to 2007 
(N=714) 
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Figure 7   Deaths due to trauma, by type of death, NDRDI 1998 to 2007 (N=714) 
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Figure 8   Deaths among drug users due to trauma, by place of residence, NDRDI 1998 to 2007 
(N=700) 
 
 
 
 
Deaths due to medical causes 
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Figure 9   Deaths among drug users due to medical causes, by age group, NDRDI 1998 to 2007 
(N=469) 
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Figure 10   Deaths among drug users due to medical causes, by type, NDRDI 1998 to 2007 
(N=469) 
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Figure 11   Deaths among drug users due to medical causes, by place of residence, NDRDI 1998 
to 2007 (N=460) 
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